company background image
BIO

BIOTON WSE:BIO Stock Report

Last Price

zł3.88

Market Cap

zł332.7m

7D

-1.6%

1Y

6.7%

Updated

26 Sep, 2023

Data

Company Financials

BIO Stock Overview

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

BIO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

BIOTON S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BIOTON
Historical stock prices
Current Share Pricezł3.88
52 Week Highzł4.10
52 Week Lowzł3.26
Beta0.16
1 Month Change-2.39%
3 Month Change6.90%
1 Year Change6.75%
3 Year Change-8.82%
5 Year Change-32.61%
Change since IPO-96.85%

Recent News & Updates

Recent updates

We Think BIOTON (WSE:BIO) Is Taking Some Risk With Its Debt

Mar 21
We Think BIOTON (WSE:BIO) Is Taking Some Risk With Its Debt

The Strong Earnings Posted By BIOTON (WSE:BIO) Are A Good Indication Of The Strength Of The Business

Sep 08
The Strong Earnings Posted By BIOTON (WSE:BIO) Are A Good Indication Of The Strength Of The Business

Shareholder Returns

BIOPL BiotechsPL Market
7D-1.6%-4.1%-1.1%
1Y6.7%3.0%27.2%

Return vs Industry: BIO exceeded the Polish Biotechs industry which returned 3% over the past year.

Return vs Market: BIO underperformed the Polish Market which returned 27.2% over the past year.

Price Volatility

Is BIO's price volatile compared to industry and market?
BIO volatility
BIO Average Weekly Movement2.4%
Biotechs Industry Average Movement4.8%
Market Average Movement5.0%
10% most volatile stocks in PL Market10.1%
10% least volatile stocks in PL Market3.2%

Stable Share Price: BIO is less volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: BIO's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989357Jeremy Laundershttps://www.bioton.pl

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

BIOTON S.A. Fundamentals Summary

How do BIOTON's earnings and revenue compare to its market cap?
BIO fundamental statistics
Market Capzł332.72m
Earnings (TTM)zł4.38m
Revenue (TTM)zł218.48m

76.0x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIO income statement (TTM)
Revenuezł218.48m
Cost of Revenuezł123.94m
Gross Profitzł94.54m
Other Expenseszł90.16m
Earningszł4.38m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Oct 31, 2023

Earnings per share (EPS)0.051
Gross Margin43.27%
Net Profit Margin2.00%
Debt/Equity Ratio10.4%

How did BIO perform over the long term?

See historical performance and comparison